MARINOMED BIOTECH AG INH.
MARINOMED BIOTECH AG INH./ ATMARINOMED6 /
93Z
|
11/11/2024 3:26:53 PM
|
Chg.
+0.600
|
Volume |
Bid3:26:53 PM |
Ask3:26:53 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
7.900EUR
|
+8.22%
|
-
Turnover: - |
7.900Bid Size: - |
8.640Ask Size: - |
12.87 mill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-4.50 EUR |
4.65% |
| EPS Diluted: |
- EUR |
4.65% |
| Revenues per Share: |
6.05 EUR |
-19.19% |
| Book Value per Share: |
-6.67 EUR |
142.16% |
| Cash Flow per Share: |
-2.98 EUR |
-13.77% |
| Dividend per Share: |
- EUR |
- |
| Total |
in mill. |
|
| Revenues: |
9.18 EUR |
-18.54% |
| Net Income: |
-6.79 EUR |
6.16% |
| Operating Cash Flow: |
-4.52 EUR |
- |
| Cash and Cash Equivalents: |
2.58 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
1.40 |
4.83 |
| P/BV ratio: |
-1.27 |
-4.38 |
| P/CF Ratio: |
-2.85 |
-9.81 |
| PEG: |
-0.41 |
- |
| Earnings Yield: |
-53.07% |
-15.41% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
12.87 mill. EUR |
44.33 mill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
247,582.3928 EUR |
852,524.3231 EUR |
| Shares Outstanding: |
1.52 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
-55.77% |
| Net Profit Margin: |
-74.01% |
| Return on Equity: |
- |
| Return on Assets: |
-46.50% |
Financial Strength
| Liquidity I / Cash Ratio: |
26.74% |
| Liquidity II / Quick Ratio: |
63.32% |
| Liquidity III / Current Ratio: |
73.89% |
| Debt / Equity Ratio: |
- |
| Dynam. Debt / Equity Ratio: |
-547.35% |
Efficiency
| Employees: |
52 |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
176,538.46 EUR |
| Net Income / Employee: |
-130,653.85 EUR |
| Total Assets / Employee: |
280,961.54 EUR |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
